September 03, 2019
Giving healthcare companies the exposure they deserve. Every Tuesday.
BioTuesdays by Kilmer Lucas


Interface Biologics sells Endexo surface modification business, sharpens focus on Epidel drug delivery platform

Closely-held Interface Biologics is selling its Endexo surface modification business and shifting its focus to its Epidel drug delivery technology, initially for ophthalmic indications.

Earlier today, Interface reported that it sold its Endexo business to Germany-based Evonik Industries (EVR:ETK), a multi-billion dollar specialty chemical company with a strong focus on its healthcare business line. “We’ve been working with Evonik for the past three years on several joint development programs and, over last six months, have been negotiating with them about acquiring our Endexo business,” president and CEO, Tom Reeves, says in an interview with BioTuesdays.

The sale does not include the license Interface granted to Fresenius Medical Care (NYSE:FMS) for the use of Endexo in chronic and acute dialysis systems, which dates back to 2010. “The Fresenius agreement is a significant commercial opportunity for Interface and with the completion of their clinical trial earlier this year, we’re hopeful that they will have regulatory approval next year,” Mr. Reeves said.
Read the Story



Itamar Medical

AGP starts coverage of Itamar Medical at buy; PT $15.50


Roth Capital Markets

Zegbeh Jallah joins Roth heath care research team


TRACON Pharmaceuticals

HCW starts TRACON Pharma at buy; PT $2


Zenabis Global

Outperforms cannabis design capacity by 46% in July

More Briefs


About BioTuesdays

BioTuesdays was created in 2009 by Kilmer Lucas, a leading healthcare-only investor relations firm. Employing a unique "outsourced in-house" partnership model, Kilmer Lucas designs and executes customized IR & PR programs for its drug development, medical device, cell therapy, diagnostics and healthcare services clients. But, most of BioTuesdays' content isn't client-driven. Rather, our mission is to give as many great healthcare companies and their stories as much exposure as we can.
Want to be featured in BioTuesdays? Get in touch with us.
Copyright © 2019 Kilmer Lucas, All rights reserved.
You are receiving this email because you signed up for the BioTuesdays newsletter.
Privacy Policy

PO Box 297
Carlisle, ON L0R 1H0 

subscribe | unsubscribe | update your preferences